AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs SABS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline KimberlyClark KMB Q1 2026 Earnings EPS Surpasses Estimates as Cost Discipline Lifts Profitability OHI Q1 2026 Earnings REIT Beats EPS Estimates Despite Soft Market Reaction BMRA Q1 2026 Earnings Loss of 044 Per Share Amid No Revenue Disclosure CRNX Q1 2026 Earnings Narrowed Loss Per Share Slightly Below Expectations